Evans J M, Turner B A, Bowen S, Ho A M, Sarver R W, Benson E, Parker C N
Global High Throughput Screening, Pharmacia Corp., Kalamazoo, MI 49007, USA.
Bioorg Med Chem Lett. 2003 Mar 24;13(6):993-6. doi: 10.1016/s0960-894x(03)00085-4.
Screening for inhibitors of bacterial protein synthesis Initiation Factor 2 (IF2) binding to N-formyl-Methionyl-transfer RNA (fMet-tRNA((fMet))) identified a series of aminoglycosides, that included amikacin and kanamycin A1, as inhibitors of this interaction. Subsequent testing revealed that aminoglycosides displayed a wide range of inhibitory activity. However, the failure of these compounds to completely inhibit binding of IF2 to fMet-tRNA((fMet)), the known ability of aminoglycosides to bind RNA, and the ability of the aminoglycosides to displace PicoGreen bound to fMet-tRNA((fMet)) suggest these compounds act by binding fMet-tRNA((fMet)). This hypothesis is further supported by isothermal denaturation experiments that failed to show any interaction between the IF2 protein and the aminoglycosides.
对细菌蛋白质合成起始因子2(IF2)与N-甲酰甲硫氨酰转运RNA(fMet-tRNA((fMet)))结合的抑制剂进行筛选,鉴定出一系列氨基糖苷类药物,其中包括阿米卡星和卡那霉素A1,它们可抑制这种相互作用。后续测试表明,氨基糖苷类药物具有广泛的抑制活性。然而,这些化合物未能完全抑制IF2与fMet-tRNA((fMet))的结合、氨基糖苷类药物已知的与RNA结合的能力,以及氨基糖苷类药物取代与fMet-tRNA((fMet))结合的PicoGreen的能力,这表明这些化合物通过与fMet-tRNA((fMet))结合发挥作用。等温变性实验未能显示IF2蛋白与氨基糖苷类药物之间存在任何相互作用,这进一步支持了这一假设。